Outcomes and complications in critically ill patients with coronavirus disease 2019 pneumonia
| Variable | No. (%) of patients* n = 106 |
|---|---|
| Outcomes | |
| Hospital mortality | 21 (19.8) |
| ICU mortality | 18 (17.0) |
| ICU mortality in mechanically ventilated patients, n = 65 | 12 (18.5) |
| Currently on medical ward† | 4 (3.8) |
| Duration of mechanical ventilation, d, median (IQR) | 12 (8–18) |
| ICU length of stay, d, median (IQR) | 10 (4–17) |
| Hospital length of stay, d, median (IQR) | 19 (10–31) |
| Tracheostomy | 7 (6.6) |
| Complications | |
| ICU-acquired infection‡ | 22 (20.8) |
| Atrial fibrillation | 24 (22.6) |
| Acute kidney injury§ | 20 (18.9) |
| Renal replacement therapy | 12 (11.3) |
| Thrombotic events¶ | 16 (15.1) |
| Pulmonary embolism or deep vein thrombosis | 12 (11.3) |
| Ischemic stroke | 7 (6.6) |
| Peripheral arterial thrombosis | 1 (0.9) |
Note: ICU = intensive care unit, IQR = interquartile range.
↵* Unless stated otherwise.
↵† Two patients awaiting rehabilitation and 2 patients awaiting long-term care.
↵‡ Positive culture results with pathogenic organisms.
↵§ Greater than 2 times baseline creatinine.
↵¶ Thromboembolic event confirmed by imaging; 2 patients had > 1 thrombotic events.